Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer

Editor’s Choice: Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study Editorial: Implications of the Platinum-Free Interval in Endometrial Cancer: A Legacy Worth Leaving Behind? Hosted by: Warner Huh, MD, Deputy Editor of Gynecologic Oncology Featuring: Paulina Haight, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, Columbus, OH, United States of America Ramez N. Eskander, MD, UC San Diego School of Medicine, Moores Cancer Center at UC San Diego Health, San Diego, CA Check out more content on the journal's homepage at

You can listen to Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer is an episode from Gynecologic Oncology by Health Advance.

This episode is 16:12 long.

This episode was published on Mar 26, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Gynecologic Oncology when more episodes are available from the podcast feed.